Prevnar 20 syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FDABC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,229
Award facts
- Contract value 100% obligated
- $14,229.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Prevnar 20 syringes (0.5mL) valued at $14,229.13 under a firm fixed price contract. The award was made on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a non-set-aside competitive procurement. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical federal vendor through its capacity to supply a broad spectrum of pharmaceutical products and medical supplies to defense and veteran healthcare systems. The Prevnar 20 vaccine procurement supports the Defense Health Agency and broader military medical supply requirements. As a child contract under the SPE2DX IDC, this delivery order exemplifies the company's role within DLA's pharmaceutical supply chain, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The Defense Logistics Agency anticipates establishing Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among key suppliers for this strategic initiative.
Quick answers
Who was awarded contract SPE2DB25FDABC?
SPE2DB25FDABC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FDABC worth?
The government has obligated $14,229 on SPE2DB25FDABC.
Is contract SPE2DB25FDABC an order under another contract?
Yes. SPE2DB25FDABC is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FDABC competed?
The extent of competition for SPE2DB25FDABC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award